We used multiple cell lines, including MGMT-methylated (U87 and GCE-77) and MGMT-unmethylated (GIN-28 and GIN-31) cell lines, to be more representative of the clinical challenges of GBM treatment. Here, MGMT is linked to glioblastoma.